| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics |
Drug Discovery Program [M. A. B., J. S., S. M. S.] and Molecular Oncology Program [J. T., R. J.], Biostatistics and Informatics Core [A. C.], H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, and Departments of Oncology and Biochemistry and Molecular Biology, University of South Florida, Tampa, Florida 33612 [M. A. B., J. S., J. T., R. J., S. M. S.]
Constitutively activated, tyrosine-phosphorylated signal transducer and activator of transcription (STAT) 3 plays a pivotal role in human tumor malignancy. To discover disrupters of aberrant STAT3 signaling pathways as novel anticancer drugs, we developed a phosphotyrosine STAT3 cytoblot. Using this high throughput 96-well plate assay, we identified JSI-124 (cucurbitacin I) from the National Cancer Institute Diversity Set. JSI-124 suppressed the levels of phosphotyrosine STAT3 in v-Src-transformed NIH 3T3 cells and human cancer cells potently (IC50 value of 500 nM in the human lung adenocarcinoma A549) and rapidly (complete inhibition within 1–2 h). The suppression of phosphotyrosine STAT3 levels resulted in the inhibition of STAT3 DNA binding and STAT3-mediated but not serum response element-mediated gene transcription. JSI-124 also decreased the levels of tyrosine-phosphorylated Janus kinase (JAK) but not those of Src. JSI-124 was highly selective for JAK/STAT3 and did not inhibit other oncogenic and tumor survival pathways such as those mediated by Akt, extracellular signal-regulated kinase 1/2, or c-Jun NH2-terminal kinase. Finally, JSI-124 (1 mg/kg/day) potently inhibited the growth in nude mice of A549 tumors, v-Src-transformed NIH 3T3 tumors, and the human breast carcinoma MDA-MB-468, all of which express high levels of constitutively activated STAT3, but it did not affect the growth of oncogenic Ras-transformed NIH 3T3 tumors that are STAT3 independent or of the human lung adenocarcinoma Calu-1, which has barely detectable levels of phosphotyrosine STAT3. JSI-124 also inhibited tumor growth and significantly increased survival of immunologically competent mice bearing murine melanoma with constitutively activated STAT3. These results give strong support for pharmacologically targeting the JAK/STAT3 signaling pathway for anticancer drug discovery.
This article has been cited by other articles:
|
|
 |
|
  R. Satou, R. A. Gonzalez-Villalobos, K. Miyata, N. Ohashi, A. Katsurada, L. G. Navar, and H. Kobori Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells Am J Physiol Renal Physiol, July 1, 2008; 295(1): F283 - F289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Garza, M. Guo, W. Zhang, and X.-Y. Lu Leptin Increases Adult Hippocampal Neurogenesis in Vivo and in Vitro J. Biol. Chem., June 27, 2008; 283(26): 18238 - 18247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-F. Mashreghi, R. Klemz, I. S. Knosalla, B. Gerstmayer, U. Janssen, R. Buelow, A. Jozkowicz, J. Dulak, H.-D. Volk, and K. Kotsch Inhibition of Dendritic Cell Maturation and Function Is Independent of Heme Oxygenase 1 but Requires the Activation of STAT3 J. Immunol., June 15, 2008; 180(12): 7919 - 7930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gagnon, S. Ramanathan, C. Leblanc, A. Cloutier, P. P. McDonald, and S. Ilangumaran IL-6, in Synergy with IL-7 or IL-15, Stimulates TCR-Independent Proliferation and Functional Differentiation of CD8+ T Lymphocytes J. Immunol., June 15, 2008; 180(12): 7958 - 7968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Kung and N. Raab-Traub Epstein-Barr Virus Latent Membrane Protein 1 Induces Expression of the Epidermal Growth Factor Receptor through Effects on Bcl-3 and STAT3 J. Virol., June 1, 2008; 82(11): 5486 - 5493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Z. Cheng, W. Zhang, M. Sun, Q. Wang, D. Coppola, M. Mansour, L. Xu, C. Costanzo, J. Q. Cheng, and L.-H. Wang Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function J. Biol. Chem., May 23, 2008; 283(21): 14665 - 14673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Brantley and E. N. Benveniste Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas Mol. Cancer Res., May 1, 2008; 6(5): 675 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, X. Zhu, K. Sasaki, R. Ueda, K. L. Low, I. F. Pollack, and H. Okada Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial Glioma J. Immunol., February 15, 2008; 180(4): 2089 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Germain and D. A. Frank Targeting the Cytoplasmic and Nuclear Functions of Signal Transducers and Activators of Transcription 3 for Cancer Therapy Clin. Cancer Res., October 1, 2007; 13(19): 5665 - 5669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dziennis, T. Jia, O. K. Ronnekleiv, P. D. Hurn, and N. J. Alkayed Role of Signal Transducer and Activator of Transcription-3 in Estradiol-Mediated Neuroprotection J. Neurosci., July 4, 2007; 27(27): 7268 - 7274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Agarwal, A. Tyagi, M. Kaur, and R. Agarwal Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells Carcinogenesis, July 1, 2007; 28(7): 1463 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Siddiquee, S. Zhang, W. C. Guida, M. A. Blaskovich, B. Greedy, H. R. Lawrence, M. L. R. Yip, R. Jove, M. M. McLaughlin, N. J. Lawrence, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity PNAS, May 1, 2007; 104(18): 7391 - 7396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Huang Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications Clin. Cancer Res., March 1, 2007; 13(5): 1362 - 1366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. B. AGGARWAL, G. SETHI, K. S. AHN, S. K. SANDUR, M. K. PANDEY, A. B. KUNNUMAKKARA, B. SUNG, and H. ICHIKAWA Targeting Signal-Transducer-and-Activator-of-Transcription-3 for Prevention and Therapy of Cancer: Modern Target but Ancient Solution Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 151 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Dalton and K. C. Anderson Synopsis of a Roundtable on Validating Novel Therapeutics for Multiple Myeloma. Clin. Cancer Res., November 15, 2006; 12(22): 6603 - 6610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Petropavlovskaia, J. Makhlin, J. Sampalis, and L. Rosenberg Development of an in vitro pancreatic tissue model to study regulation of islet neogenesis associated protein expression. J. Endocrinol., October 1, 2006; 191(1): 65 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maggio, J. M. Guralnik, D. L. Longo, and L. Ferrucci Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2006; 61(6): 575 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cheng, H. Wang, A. Suarez, P. Horna, S. Sebti, and E. M. Sotomayor Cucurbitacins, a Family of Natural Compounds That Effectively Disrupt Stat3 Signaling in Antigen-Presenting Cells (APCs) Are Promising Agents To Overcome Tumor-Induced CD4+ T-Cell Tolerance. Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 1485 - 1485. [Abstract]
|
|
|
|
 |
|
 Y. Nefedova, S. Nagaraj, A. Rosenbauer, C. Muro-Cacho, S. M. Sebti, and D. I. Gabrilovich Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway Cancer Res., October 15, 2005; 65(20): 9525 - 9535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nefedova, P. Cheng, D. Gilkes, M. Blaskovich, A. A. Beg, S. M. Sebti, and D. I. Gabrilovich Activation of Dendritic Cells via Inhibition of Jak2/STAT3 Signaling J. Immunol., October 1, 2005; 175(7): 4338 - 4346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gao, L. Zhang, J. Hu, F. Li, Y. Shao, D. Zhao, D. V. Kalvakolanu, D. J. Kopecko, X. Zhao, and D.-Q. Xu Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo Clin. Cancer Res., September 1, 2005; 11(17): 6333 - 6341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Catalano, M. H. Johnson, E. A. Campbell, D. S. Charnock-Jones, S. K. Smith, and A. M. Sharkey Inhibition of Stat3 activation in the endometrium prevents implantation: A nonsteroidal approach to contraception PNAS, June 14, 2005; 102(24): 8585 - 8590. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nam, R. Buettner, J. Turkson, D. Kim, J. Q. Cheng, S. Muehlbeyer, F. Hippe, S. Vatter, K.-H. Merz, G. Eisenbrand, et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells PNAS, April 26, 2005; 102(17): 5998 - 6003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Song, R. Wang, S. Wang, and J. Lin A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells PNAS, March 29, 2005; 102(13): 4700 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Molnarfi, N. Hyka-Nouspikel, L. Gruaz, J.-M. Dayer, and D. Burger The Production of IL-1 Receptor Antagonist in IFN-{beta}-Stimulated Human Monocytes Depends on the Activation of Phosphatidylinositol 3-Kinase but Not of STAT1 J. Immunol., March 1, 2005; 174(5): 2974 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Christine, R. Sylvie, B. Erik, P. Genevieve, R. Amelie, R. Gerard, B. Marc, G. Christian, and A. Samir Implication of STAT3 Signaling in Human Colonic Cancer Cells during Intestinal Trefoil Factor 3 (TFF3) - and Vascular Endothelial Growth Factor-Mediated Cellular Invasion and Tumor Growth Cancer Res., January 1, 2005; 65(1): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis Cancer Res., September 15, 2004; 64(18): 6603 - 6609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Spaner Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells J. Leukoc. Biol., August 1, 2004; 76(2): 338 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Park, H. Lim, K. J. Han, S. H. Baek, H. O. Sohn, D. W. Lee, Y.-G. Kim, H.-Y. Yun, K. J. Baek, and N. S. Kwon Inhibition of Nitric Oxide Generation by 23,24-Dihydrocucurbitacin D in Mouse Peritoneal Macrophages J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 705 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nagel-Wolfrum, C. Buerger, I. Wittig, K. Butz, F. Hoppe-Seyler, and B. Groner The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells Mol. Cancer Res., March 1, 2004; 2(3): 170 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. He, L. You, K. Uematsu, K. Zang, Z. Xu, A. Y. Lee, J. F. Costello, F. McCormick, and D. M. Jablons SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer PNAS, November 25, 2003; 100(24): 14133 - 14138. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
